FIELD: medicine, gastroenterology.
SUBSTANCE: invention can be used for non-invasive diagnostics of non-alcoholic fatty liver disease in men. The patient is examined with determination of height, body weight, waist circumference and calculation of body mass index. By filling out the IPAQ questionnaire by the patient, the presence of hypodynamia, carbohydrate metabolism disorders, the level of immunoreactive insulin and high-density lipoproteins are detected. After that, the probability of the presence of the disease is calculated according to the original formula.
EFFECT: method allows to increase the accuracy of forecasting, to identify risk groups, to ensure that the examination is carried out on an outpatient basis.
1 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PROGRESSIVE CLINICAL COURSE OF EARLY FORMS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2768466C1 |
| METHOD OF DETERMINING THE RISK OF SEVERE LIVER STEATOSIS | 2023 |
|
RU2806496C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
| SCREENING DIAGNOSING METHOD FOR FATTY LIVER DEGENERATION ACCOMPANYING ABDOMINAL OBESITY | 2018 |
|
RU2684201C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
| METHOD FOR CHOOSING A TECHNIQUE FOR SURGICAL TREATMENT OF OBESE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2751418C1 |
| METHOD FOR NON-INVASIVE DIAGNOSIS OF ALCOHOLIC LIVER DISEASE IN MALES | 2022 |
|
RU2814367C1 |
| METHOD FOR DETERMINATION OF ATHEROSCLEROTIC DAMAGE OF VASCULAR WALL IN PATIENTS WITH ABDOMINAL OBESITY AND NONALCOLORAL FAT LIVER DISEASE (VERSIONS) | 2016 |
|
RU2637412C1 |
| METHOD FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN OF THE EUROPEAN POPULATION DURING SCREENING EXAMINATIONS | 2021 |
|
RU2760092C1 |
| MINIMALLY INVASIVE METHOD FOR DIAGNOSING NON-ALCOHOLIC FATTY LIVER DISEASE BASED ON THE IDENTIFICATION OF MIRNAS AND MIP-1β IN BLOOD PLASMA | 2022 |
|
RU2798163C1 |
